BENFVSGTBP• 28 Days (Normalized)
BENF vs GTBP (Beneficient vs GT Biopharma Inc.)
Showing Closing Date Range from Aug 28 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BENF Performance $2.9
+27.98%
Beneficient
Normalized Baseline0.00%
GTBP Performance $7.1
+2266.67%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-2238.69 pts
GTBP outperforming by 2238.69 percentage points
BENFGTBP
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BENF GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(18 dates)
| Date | BENF Price | BENF Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $2.90 | +27.98% | $7.10 | +2266.67% | -2238.69% |
| Sep 22, 2026 | $0.54 | -76.26% | $- | - | |
| Sep 21, 2026 | $0.56 | -75.42% | $7.18 | +2293.33% | -2368.75% |
| Sep 18, 2026 | $0.56 | -75.20% | $7.16 | +2286.67% | -2361.87% |
| Sep 17, 2026 | $0.63 | -72.24% | $7.49 | +2396.67% | -2468.91% |
| Sep 16, 2026 | $0.82 | -63.86% | $7.81 | +2503.33% | -2567.19% |
| Sep 15, 2026 | $0.60 | -73.43% | $9.00 | +2900.00% | -2973.43% |
| Sep 14, 2026 | $0.81 | -64.44% | $11.63 | +3776.67% | -3841.11% |
| Sep 11, 2026 | $1.06 | -53.22% | $8.61 | +2770.00% | -2823.22% |
| Sep 10, 2026 | $1.21 | -46.51% | $6.18 | +1960.00% | -2006.51% |
| Sep 09, 2026 | $1.68 | -25.86% | $5.98 | +1893.33% | -1919.19% |
| Sep 08, 2026 | $1.80 | -20.79% | $- | - | |
| Sep 04, 2026 | $2.33 | +2.82% | $0.24 | -19.67% | +22.49% |
| Sep 03, 2026 | $2.15 | -5.12% | $0.25 | -16.00% | +10.88% |
| Sep 02, 2026 | $2.03 | -10.41% | $0.28 | -5.67% | -4.74% |
Page 1 of 2